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Craniula: A cranial window technique 
for prolonged imaging of brain surface 
vasculature with simultaneous adjacent 
intracerebral injection
Viviana Zuluaga‑Ramirez1†, Slava Rom2† and Yuri Persidsky3*
Abstract 
Background: Imaging of the brain surface vasculature following inflammatory insults is critical to study structural 
and functional changes in the living brain under normal and pathological conditions. Although there have been pub‑
lished reports relating to the changes that occur in the blood brain barrier (BBB) during the inflammatory process, the 
ability to visualize and track such changes in vivo and over time has proven to be problematic. Different techniques 
have been used to achieve visualization of pial vessels, but the approach has limits, which can jeopardize the well‑
being of the animals. Development of the cranial window technique provided a major advance in the acquisition of 
live images of the brain vasculature and its response to different insults and treatments.
Methods: We describe in detail a protocol for delivery of a localized inflammatory insult to the mouse brain via a 
craniula (cranial window and adjacent cannula) and subsequent imaging of the mouse brain vasculature by intravital 
microscopy and two‑photon laser scanning microscopy. The surgical implantation of the craniula can be completed 
in 30‑45 min and images can be acquired immediately and for several months thereafter. The technique is minimally 
invasive and permits serial injections directly to the brain, thereby allowing longitudinal imaging studies. The craniula 
technique permits the study of structural and functional changes of the BBB following inflammatory insult and as 
such has wide application to neuroscience research.
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Background
In vivo imaging of the brain vasculature to assess interac-
tions of different leukocyte types within the blood brain 
barrier (BBB) has been challenging. Although there have 
been published reports related to the changes that occur 
in the BBB during the inflammatory process [1–4], the 
ability to visualize and track such changes over time and 
in vivo has proven to be problematic. Techniques such as 
skull-thinning [5] have been used to achieve visualization 
of pial vessels, but the approach has limits due to skin 
manipulation and wound management, which can jeop-
ardize the well-being of the animals. On the other hand, 
this complication has not been reported on cranial win-
dows, since the skin is actually removed from the skull 
and no further wound manipulation is required [6]. 
Development of the cranial window technique has pro-
vided a major advance in the acquisition of live images of 
the brain vasculature and its response to different insults 
and treatments [7–9]. Systemic administration of inflam-
matory stimuli [such as lipopolysaccharide (LPS) or 
tumor necrosis factor alpha (TNFα)] has been used with 
the cranial window technique to investigate leukocyte–
brain endothelial interactions [7, 8, 10–13]. However, 
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or other insult specifically to the brain parenchyma 
(mimicking neuroinflammation) and to visualize simul-
taneously in vivo changes in the brain microvasculature.
Implantation of cannulae into brain has previously been 
employed to permit constant infusion of substances into 
the central nervous system (CNS) [14, 15]. However, this 
technique allows evaluation of only one time point in an 
animal and requires the tissue to be harvested in order to 
examine structural changes in the brain [14]. In addition, 
the size and low bone density of the mouse skull (com-
pared to the rat skull) present further technical complica-
tions [14]. Even though a technique has been published 
which creates an insult adjacent to a cranial window on 
a mouse skull, such approach is unlikely to permit serial 
injections [16]. Recently, a removable cranial window 
technique has been described [6] allowing intracerebral 
injections. Nevertheless, this technique does not allow 
simultaneous injection of an insult and visualization of 
leukocyte interactions with brain microvasculature with-
out exposing the brain tissue during injection.
Another method has been described in which a sili-
cone plug is placed in a hole cut in the glass window to 
allow microinjections into the brain [17]. However, only 
small volumes can be injected via micropipettes, which 
limits this technique. Using our craniula technique 
described here, up to 5  µL can be safely injected into 
the mouse brain; along with any cell type, given that the 
inner cannula has an internal diameter of 0.1 mm (33 ga). 
Moreover, the silicone port poses a further impedi-
ment that is not seen with our technique, namely dura 
regrowth under the silicone plug, which inhibits access 
for injections.
To address these unmet needs, we have developed a 
technique, termed “craniula”, composed of a glass cranial 
window for visualizing brain surface vessels, combined 
with an adjacent implanted cannula for intraparenchy-
mal injection (Fig. 1). This permits repeated intracerebral 
injections and simultaneous in vivo imaging of the mouse 
brain over several months.
Methods
Animals
We have followed the approach of the well-known cra-
nial window technique for mice that has been described 
in detail by Zhang and colleagues [9, 18]. We have added 
several important variations to the procedure that lead 
to our proposed craniula technique. A complete list of 
surgical tools and reagents used is described in detail in 
Table  1. All animal experiments were approved by the 
Temple University Institutional Animal Care and Use 
Committee and conducted in accordance with Temple 
University guidelines, which are based on the National 
Institutes of Health (NIH) guide for care and use of labo-
ratory animals and with the ARRIVE (Animal Research: 
Reporting In Vivo Experiments) guidelines (study 
design, experimental procedures, housing and hus-
bandry, statistical methods) (http://www.nc3rs.org.uk/
arrive-guidelines).
Forty mice (C57BL/6, Jackson Laboratory, Bar Harbor, 
ME, USA stock# 000664) were used in our study. Asep-
tic conditions are maintained throughout procedure to 
minimize any possible contamination that can create an 
inappropriate environment due to external inflammatory 
stimuli.
Fig. 1 Schematic diagram of craniula position on the mouse skull. Adapted from Rat Skull (images source: 3D Rat Anatomy Software from bio‑
sphera.org) [28]
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Intracerebral injection cannula
A commercially available, custom-made cannula is the 
key of our technique (PlasticsOne, Roanoke, VA, USA). 
The size and projection lengths can be adjusted for indi-
vidual purposes making the technique suitable for dif-
ferent approaches in diverse neuroscience fields. The 
intracerebral (IC) injection cannula consists of a guide 
cannula: (cat no. C315GS-2/SP, 0.5 mm length); a dummy 
cannula: (cat no. C315DCS-2/SP, to fit C315GS-2/SP, 
without projection); and an infusion cannula: (cat no. 
C315IS-2/SP, to fit 0.5  mm C315GS-2/SP with 1  mm 
projection.)
Surgical procedure
Male mice, 8–10 weeks old, average weight 22 g, are anes-
thetized with 3–5  % isoflurane. The head is shaved from 
the nasal septum up to the occipital bone (between ears) 
and Puralube® ointment is applied to each eye. Isoflurane 
is reduced to 2.0 % as a maintenance dosage. The depth of 
anesthesia is monitored by loss of pinna and rear toe pinch 
reflex. Respiration is observed and normal body tempera-
ture maintained with a rodent Deltaphase® pad during the 
procedure. Once the mouse is fully anesthetized, dexameth-
asone is administered (0.02 ml at 4 mg/ml) by subcutaneous 
injection to minimize inflammation. The mouse is posi-
tioned in a stereotactic head holder/gas mask (Fig.  2a). 
The surgical area is cleaned by 70 % alcohol and 2 % iodine 
solution. A 1 cm area of skin is excised on the dorsal sur-
face of the skull over the right cortical hemisphere. The first 
major variation from a regular cranial window technique is 
to create a 0.5 mm circular foramen for the IC cannula with 
a high-speed drill over the parietal bone, 0.1 mm posterior 
to bregma and 0.1  mm to the right of the sagittal suture 
(Fig. 2b). This is one of the most delicate steps in the pro-
cedure; in case of failure (drilling though the skull bone), 
the experiment should be discontinued. Therefore, drilling 
should be done slowly and gently. The second main varia-
tion is that the actual cranial window for visualization of 
the brain surface should not exceed 4 mm in diameter and 
should be located no less than 1 mm distant from the fora-
men created for the IC cannula. This will guarantee enough 
space between the glass cover slip of the cranial window and 
the cannula pedestal. Only when these conditions are met 
can the cranial window procedure be followed.
Briefly, a light outline on the cranial window (3–4 mm 
diameter) is drawn with a high-speed drill (Fig. 2b). The 
skull is irrigated at all times with sterile PBS. When an 
obvious movement of the skull bone is observed (by 
Table 1 Reagents/supplies and surgical tools required to perform the procedure
Surgical Tool Company Catalog No.
Standard forceps, Dumont #5 Fine Science Tools Inc., Foster City, CA, USA 11251‑30
Micro points, stainless steel, 15.5 cm, 45 degrees Fine Science Tools 10066‑15
Double‑pronged tissue pick, 11 cm, stainless steel Fine Science Tools 18067‑11
Moria Bonn scissors, Inox, 9 cm, straight, sharp–sharp Fine Science Tools 14381‑43
Hot glass‑bead sterilizer Fine Science Tools 18000‑45
Stereotaxic frame Stoelting Co., Wood Dale, IL, USA 51600
Gas anesthesia mask for mouse stereotactics Harvard apparatus Inc, Holliston, MA, USA 51609 M
High‑speed drill (Ideal Micro‑Drill™ CellPoint Scientific, Gaithersburg, MD, USA 67‑1200
Inhalational anesthesia vaporizer EZ Anesthesia, Palmer, PA, USA EZ‑7000
Deltaphase® Isothermal Pad Braintree Scientific Inc., Braintree, MA, USA 39 DP
Dissecting microscope Carl Zeiss AG, Oberkochen, Germany Stemi 2000
Reagents and Supplies Company Catalog no.
Dexamethasone 2 mg/ml Clipper Distributing Company, St Joseph, MO, USA 18105‑01
Isoflurane Vedco Inc., St Joseph, MO, USA NDC 50989‑150‑15
Alcohol prep pads Thermo Fisher Scientific, Waltham, MA, USA 22363750
PDI™ Povidone‑Iodine Prep Pad Thermo Fisher Scientific 06‑669‑70
Saline solution (PBS) 0.9 % Thermo Fisher Scientific S5815
Artificial cerebral spinal fluid (ACSF) Tocris Bioscience, Bristol, United Kingdom 3525
Puralube® vet ophthalmic ointment Dechra Pharmaceuticals, Northwich, United Kingdom NA
Super Glue LocTite® LocTite® Brand–Consumer Products Henkel Corporation,  
Westlake, OH, USA
LOC1364076
Syringe, BD™ slip tip sterile Thermo Fisher Scientific 309659
Trimmer, Safe T‑Light Braintree Scientific CLP‑24 090
3 M™ Vetbond™ glue Thermo Fisher Scientific NC9604126
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gentle touch) this piece can be lifted from the skull with 
forceps. When the brain is exposed, it is irrigated with 
sterile artificial cerebral spinal fluid (ACSF). Failure to 
keep brain tissue irrigated will desiccate the dura, thereby 
increasing the chances for bleeding or abrupt disruption 
of major blood vessels, when the dura is removed. Using 
Fig. 2 Surgical procedure. a Mouse immobilized on stereotactic stage. b Outlined foramen for intracerebral cannula (0.5 mm diameter) next to 
the cranial window circle. c Cranial window after dura removal. d Cover slip glued to the cranial window with Vetbond™. e Cannula positioned and 
glued to the mouse skull. Insert shows magnified view of the craniula. The dashed lines denote bregma and sagittal sutures. Scale bars 1 mm
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a 45° microprobe, remove the dura by moving the probe 
horizontally until the dura is hooked. Dura mater is a 
very thin layer that may create massive bleeding if it is 
not properly removed. Proper training is advised for new 
personnel that might not be familiar with the appearance 
of the dura mater. Gently pull and move the membrane 
toward the edges of the skull. This process should be 
repeated as needed until the entire dura is removed from 
the exposed brain (Fig. 2c). Irrigate the brain with sterile 
ACSF and use forceps to place a glass cover slip over the 
window. Gently press on the cover slip with forceps. Use 
a small absorbent spear to remove excess ACSF under 
the coverslip. Add a drop of Vetbond™ in the free space 
between the skull bone and the glass cover slip (Fig. 2d).
Use Dumont #5 forceps to place a cannula (0.5  mm 
long, 33 ga) on the adjacent foramen that was created for 
the IC cannula. Position the cannula perpendicular to the 
surface of the skull and affix to the skull using Vetbond™ 
(Fig. 2e). The cannula needs to be constantly held against 
the skull. Do not release pressure from the cannula until 
the Vetbond™ has partially dried, otherwise the cannula 
will detach. In order to be certain that the glass cover 
slip and cannula are firmly attached to the skull, apply a 
second layer of glue (Super Glue LocTite®) around the 
cannula and cranial window. The area around the win-
dow (no skin and/or no fur) is covered by glue to protect 
the animal from infection. Allow the glue to solidify for 
20  min. After the second layer of super glue is applied, 
the animal can be removed from the stereotactic appara-
tus. Keep the animal in a recovery cage with a heat source 
to speed recovery.
Post‑surgery care
A recovery period of 4 days should be allowed between 
implantation of the craniula and intracerebral injections. 
Mice should be housed singly to prevent damage to the 
craniula by other mice. Cages should not contain a food 
hopper in case the cannula becomes caught or damaged, 
thereby resulting in injury to the animal. Rodent food, 
DietGel® 76A and HydroGel® should be placed on the 
floor of the cage. No other objects should be placed in the 
animal cage. Once the glue is fully cured, nestlets should 
be provided as enrichment. In our experience mice do 
not show any adverse effects or discomfort from the sur-
gical procedure.
Intracerebral (IC) injection
The mouse is anesthetized with 2.0 % inhaled isoflurane 
and immobilized on a stereotactic stage as before. IC 
injections are performed using an inner cannula custom-
ized with a 1 mm projection below the guide cannula that 
is already implanted in the mouse (Fig.  3a). The length 
of the inner cannula can be customized, depending on 
the purpose of the research project (Fig. 3a–c). Polyeth-
ylene tubing (PE-50, 2 in. in length) is connected to a 
10  μL Hamilton syringe and attached to the inner can-
nula (Fig.  3d). Prepare the tubing set up in advance to 
minimize the time under anesthesia. Remove the dummy 
from the cannula and insert the inner cannula gently. 
Make sure that the inner cannula is fully inserted. Inject 
the test compound via the cannula. The maximum rec-
ommended injection volume for the mouse brain is 
5 μL. Up to 30 μL volume has been reported to be safely 
Fig. 3 Cannula components a from left to right, dummy, guide 
cannula and inner cannula. b Inner cannula inserted into guide can‑
nula. c Cannula with screwed dummy. d Equipment for intracerebral 
(IC) injection. e Intracerebral injection in a fully anesthetize mouse, 
attached to stereotactic stage, using a nosepiece to deliver 2.0 % 
isoflurane and deliver insult via Hamilton syringe attached to an infu‑
sion cannula
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injected into the mouse brain [20]. We inject 1  μL at a 
time, with a 5-min waiting period between injections 
(Fig.  3E) to avoid any changes in intracranial pressure 
[19]. The imaging session can be done with either an 
intravital microscope as previously described [13] or a 
2-photon microscope according to the purpose of the 
research project (see below).
Intravital Video microscopy
A Stereo Discovery V20 epiflourescence microscope 
(Carl Zeiss AG, Oberkochen, Germany) was used. It has 
a large working area with 81 mm in distance between lens 
and stage and is equipped with an AxioCam MR digital 
camera. The data were analyzed by Axiovision Imaging 
Software (Carl Zeiss AG.) 5  days after craniula implan-
tation, leukocyte adhesion to and migration across the 
brain microvasculature has been assessed with intravital 
microscopy (Fig. 4 upper panel) using an in vivo injection 
of fluorescent labels. The fluorophore used depends on 
the equipment capabilities and interests. We used 0.05 % 
Rhodamine 6G for assessment of leukocyte adhesion, 
rolling and migration across pial brain vessels [18]. The 
dye injection technique does affect the outcome of imag-
ing acquisition, leaving the intravenous injection of any 
labeling agent as the preferable method [21]. We found 
that retro-orbital injection was the preferred method for 
injection of the fluorophore chosen, as has been demon-
strated for other compounds that need to be delivered 
intravenously [22]. With this technique, we have been 
able to collect videos at several time points (2 and 4  h) 
after an inflammatory insult has been delivered [13].
2‑Photon laser microscopy
We used the Leica TCS SP5 II multiphoton micro-
scope (Leica Microsystems, Wetzlar, Germany), with a 
very functional stage that allows enough space to easily 
accommodate the animal, using a water immersion objec-
tive (HCX PL APO L 20x 1.0). It has a resonant scanner 
that works at 16000 Hz frequency in a bidirectional mode 
acquiring 25 images per second with 512 ×  512 pixels, 
using FITC/TXR filter cube (156504244). The micro-
scope is equipped with LAS imaging software (Leica 
Microsystems) and images are analyzed by Imaris 7.7 
software (Bitplane, Zurich, Switzerland).
For leukocyte adhesion assessment using 2-photon 
microscopy (Fig.  4 lower panel), we have used two dif-
ferent fluorescent labels: one to label leukocytes (50  μl/
mouse 0.05 % Rhodamine 6G) and a second to label the 
vasculature (50  μl/mouse 1  % FITC-Dextran 70  kDa), 
therefore a better visual assessment of brain vascular 
architecture is achieved and further imaging analysis is 
more accurate. The settings used on LAS imaging soft-
ware for simultaneous imaging of both labels in different 
channels were as follows: laser tuned at 800  nm, Trans 
56 %, Gain 61 %, Offset 59 %, MP1 at 1 and Smart Set at 
−0.1 %. Each channel is fine-tuned using Smart Gain at 
515 for Rhodamine 6G and 480 for FITC-dextran.
Applications of the procedure
To demonstrate the utility of the craniula technique for 
delivery of an inflammatory insult and tracking subse-
quent changes in the brain vasculature without affecting 
other organs, we studied the effects of three poly(ADP-
ribose) type 1 (PARP-1) inhibitors in response to release 
of a localized inflammatory stimulus (TNFα). PARP-1 
inhibitors have been proven to be important modula-
tors of transcription factors connected with tumor pro-
gression and inflammation [23]. In order to address the 
anti-inflammatory properties of PARP-1 inhibitors at the 
BBB, we placed craniulas in 8  week-old male C57BL/6 
mice (n  =  4) per group. TNFα (0.5  μg/mouse) was 
directly injected into the brain parenchyma and PARP-1 
inhibitors (EB-47, AZD and AIQ, at 10  mg/kg each) 
were administered intra-peritoneally 2 h prior to insult. 
After 2  h from the delivery of the inflammatory insult, 
serial images were obtained using intravital microscopy 
and 2-photon laser scanning microscopy to evaluate the 
effects of TNFα insult and PARP-1 inhibitors on the brain 
microvasculature (Fig. 4). PARP-1 inhibitors significantly 
diminished leukocyte adhesion to the walls of superficial 
vessels (Fig. 4 upper panel) as well to the vessels located 
at more than 100 micron depth (Fig. 4 lower panel).
Observations from the procedure
Table 2 lists a series of observations that were addressed 
while the procedure was created along with the solutions 
to the different situations.
Discussion
After implantation, a craniula remains usable for imaging 
by epifluorescent microscopy for approximately 1 week. 
After that time, regrowth of the dura makes imaging ses-
sions challenging and inaccurate. On the other hand, a 
craniula allows imaging by 2-photon laser scanning for 
several months. Images acquired with this technique can 
go deeper, up to 850 μm into the mouse brain tissue [24], 
thus avoiding problems with dural regrowth and allow-
ing visualization of BBB vessels at a depth of over 100 μm 
(Fig. 4, lower panel), rather than superficial vessels with 
epifluorescent microscopy (Fig. 4, upper panel).
The success of the technique relies on the skills on 
the surgeon. The technique itself can be learned in rela-
tive short period of time (2–4 weeks of daily practice) 
mostly because of the skills required for placement of 
the cranial window rather than cannula placement. The 
success of image acquisition has other components, 
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including the type and method used to label target 
cells. In our experience, retro-orbital injection of the 
dye (i.e., Rhodamine 6G) is critical and provides an 
enhanced brightness in leukocytes when compared 
with intraperitoneal injection. Image acquisition using 
2-photon laser microscopy requires separate training. 
Fig. 4 Images of pial vessels using intravital epifluorescent microscopy (upper panel) and 2‑photon microscopy (lower panel). Animals were treated 
with TNFα (0.5 μg/mouse) with or without PARP‑1 Inhibitor (PARPi) EB‑47, AZD and AIQ (10 mg/kg). A reduction in the leukocyte adhesion to and 
migration across the blood brain barrier endothelium is observed. Vessels were stained with FITC‑labeled Dextran 70 (green) and leukocytes were 
labeled with Rhodamine‑6G (red/yellow color). Scale bars 100 μm
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Once the settings are known according to the type of 
fluorophore used, image acquisition is reliable. The cra-
niula technique has wide applicability in neuroscience 
research because it allows creation of localized well-
controlled inflammation in the brain. Aseptic menin-
gitis can be achieved via intracerebral TNFα injection 
with subsequent observation of leukocyte adhesion to 
and migration across the brain microvasculature as 
was described in our recent publication [13]. Personnel 
familiar with mouse surgery can easily perform the cra-
niula technique.
To demonstrate the application of this approach, we 
designed an experiment using the craniula technique. 
First, we demonstrated that an inflammatory insult 
delivered via a craniula allowed dynamic quantitative 
studies of leukocyte adhesion to and migration across 
the BBB over a period of 24  h; second, the craniula 
technique permits the study of dose-dependent inflam-
matory responses in the CNS vasculature; third, the 
craniula technique can be used with intravital micros-
copy and two-photon laser scanning microscopy to 
visualize microvessels in the brain parenchyma; fourth, 
images acquired using craniulas have the same quality 
as images acquired with cranial windows alone [8, 25, 
26].
With our novel technique, we were able to create a 
model of localized aseptic meningitis [13] where leu-
kocyte infiltration along with mild brain edema was 
detected, both known signs of meningitis [27]. Also, leu-
kocyte migration occurred across the microvasculature, 
leading to barrier injury. Therefore, the craniula can be 
very useful and can be easily reproduced for studies of 
neuroinflammation.
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